Wei Liu

Prof. Wei Liu

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
WLWei Liu
Wei Liu
TGTeng-Fei Guo
Teng-Fei Guo
ZJZhen-Tang Jing
Zhen-Tang Jing
ZYZhi Yang
Zhi Yang
LLLei Liu
Lei Liu
QTQiao-Yun Tong
Qiao-Yun Tong
Hepatitis B virus core protein (HBc) is expressed preferentially in hepatitis B virus (HBV)–associated hepatocellular carcinoma (HCC). HBc can function as an oncogene arising from its gene regulatory properties, but how it contributes functionally to hepatocarcinogenesis remains unclear. In this study, we determined the molecular and functional roles of HBc during HBV‐associated hepatocellular tumorigenesis. HBc increased tumor formation of hepatoma cells. Moreover, expression of HBc specifically promoted proliferation of hepatoma cells in vitro. Mechanistic investigations revealed that these effects were caused by activation of the Src/PI3K/Akt pathway through proximal switch from inactive Src to the active form of the kinase by HBc. HBc‐mediated sarcoma (Src) kinase activation was associated with down‐regulation of C‐terminal Src kinase (Csk). In addition, HBc enhances Src expression by activation of alternative Src 1A promoter in an Sp1 transcription factor‐dependent manner. Proliferation induced by stable HBc expression was associated with increased G 1 −S cell cycle progression mediated by Src kinase activation. HBc‐induced cellular proliferation and tumor formation were reversed by administration of the Src inhibitor saracatinib. Together, our findings suggest that HBc promotes tumorigenesis of hepatoma cells by enhancing the expression of total Src and the active form of the kinase and subsequently activates Src/ PI3K/Akt signaling pathway, revealing novel insights into the underlying mechanisms of HBV‐associated hepatocarcinogenesis.—Liu W., Guo, T.‐F., Jing Z.‐T., Yang, Z., Liu, L., Yang, Y.‐P., Lin, X., Tong Q.‐Y. Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src/PI3K/Akt pathway. FASEB J. 32, 3033–3046 (2018). www.fasebj.org

1 December 2018 in Journal of Virology
Verified
Journal Article
Open access
PDF file
SWShu-Xiang Wu
Shu-Xiang Wu
WCWan-Nan Chen
Wan-Nan Chen
ZJZhen-Tang Jing
Zhen-Tang Jing
WLWei Liu
Wei Liu
XLXin-Jian Lin
Xin-Jian Lin
XLXu Lin
Xu Lin
Hepatitis B spliced protein (HBSP) is known to associate with viral persistence and pathogenesis, however, its biological and clinical significance remains poorly defined. Acquired resistance to Fas-mediated apoptosis is thought as one of the major promotors for hepatitis B virus (HBV) chronicity and malignancy. The purpose of this study was to investigate whether HBSP could protect hepatocytes against Fas-initiated apoptosis. We showed here that HBSP mediated resistance of hepatoma cells or primary human hepatocytes (PHH) to agonistic anti-Fas antibody (CH11)- or FasL-induced apoptosis. Under Fas signaling stimulation, expression of HBSP inhibited Fas aggregation and prevented recruitment of the adaptor molecule Fas-associated death domain (FADD) and procaspase-8 (or FADD like interleukin 1 β-converting enzyme, FLICE) into the death-inducing signaling complex (DISC), while increasing recruitment of cellular FLICE-inhibitory protein L (FLIPL) into the DISC. Those effects may be mediated through activation of PI3K/AKT pathway as evidenced by increased cellular PIP3 content and PI3K activity, and enhanced phosphorylation of mTORC2 and PDPK1 as well as Akt itself. Confirmedly, inhibition of PI3K by LY294002 reversed the effect of HBSP on Fas aggregation, FLIPL expression and cellular apoptosis. These results indicate that HBSP functions to prevent hepatocytes from Fas-induced apoptosis by enhancing PI3K/Akt activity, which may contribute to the survival and persistence of infected hepatocytes during chronic infection. Importance: Our study revealed a previously unappreciated role of HBSP in Fas-mediated apoptosis. The anti-apoptotic activity of HBSP is important for understanding hepatitis B pathogenesis. In particular, HBV variants associated with hepatoma carcinoma may down-regulate apoptosis of hepatocytes through enhanced HBSP expression. Our study also found that AKT is centrally involved in Fas-induced hepatocyte apoptosis and revealed interventions directed at inhibiting the activation or functional activity of AKT may be of therapeutic value in this process.

1 May 2018 in The American Journal of Pathology
Verified
Journal Article
Closed access
WLWei Liu
Wei Liu
ZJZhen-Tang Jing
Zhen-Tang Jing
SWShu-Xiang Wu
Shu-Xiang Wu
YHYun He
Yun He
YLYan-Ting Lin
Yan-Ting Lin
XLXu Lin
Xu Lin

26 March 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MHMasaaki Hori
Masaaki Hori
AHAkifumi Hagiwara
Akifumi Hagiwara
IFIssei Fukunaga
Issei Fukunaga
RURyo Ueda
Ryo Ueda
KKKouhei Kamiya
Kouhei Kamiya
SAShigeki Aoki
Shigeki Aoki
Mapping of MR fiber g-ratio, which is the ratio of the diameter of the axon to the diameter of the neuronal fiber, is introduced in this article. We investigated the MR fiber g-ratio, the axon volume fraction (AVF) and the myelin volume fraction (MVF) to evaluate microstructural changes in the spinal cord in patients with cervical spondylotic myelopathy (CSM) in vivo, using atlas-based analysis. We used diffusion MRI data acquired with a new simultaneous multi-slice accelerated readout-segmented echo planar imaging sequence for diffusion analysis for AVF calculation and magnetization transfer saturation imaging for MVF calculation. The AVFs of fasciculus gracilis in the affected side spinal cord, fasciculus cuneatus and lateral corticospinal tracts (LSCT) in the affected and unaffected side spinal cord were significantly lower (P = 0.019, 0.001, 0019, 0.000, and 0.002, respectively) than those of normal controls. No difference was found in the MVFs. The fiber g-ratio of LSCT was significantly lower (P = 0.040) in the affected side spinal cords than in the normal controls. The pathological microstructural changes in the spinal cord in patients with CSM, presumably partial axonal degenerations with preserved myelin. This technique has the potential to be a clinical biomarker in patients with CSM in vivo.

15 October 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
ZJZhen-Tang Jing
Zhen-Tang Jing
WLWei Liu
Wei Liu
SWShu-Xiang Wu
Shu-Xiang Wu
YHYun He
Yun He
YLYan-Ting Lin
Yan-Ting Lin
XLXu Lin
Xu Lin
The Fas receptor/ligand system plays a prominent role in hepatic apoptosis and hepatocyte death. Although hepatitis B virus (HBV) surface Ag (HBsAg) is the most abundant HBV protein in the liver and peripheral blood of patients with chronic HBV infection, its role in Fas-mediated hepatocyte apoptosis has not been disclosed. In this study, we report that HBsAg sensitizes HepG2 cells to agonistic anti-Fas Ab CH11-induced apoptosis through increasing the formation of SDS-stable Fas aggregation and procaspase-8 cleavage but decreasing both the expression of cellular FLIPL/S and the recruitment of FLIPL/S at the death-inducing signaling complex (DISC). Notably, HBsAg increased endoplasmic reticulum stress and consequently reduced AKT phosphorylation by deactivation of phosphoinositide-dependent kinase-1 (PDPK1) and mechanistic target of rapamycin complex 2 (mTORC2), leading to enhancement of Fas-mediated apoptosis. In a mouse model, expression of HBsAg in mice injected with recombinant adenovirus-associated virus 8 aggravated Jo2-induced acute liver failure, which could be effectively attenuated by the AKT activator SC79. Based on these results, it is concluded that HBsAg predisposes hepatocytes to Fas-mediated apoptosis and mice to acute liver failure via suppression of AKT prosurviving activity, suggesting that interventions directed at enhancing the activation or functional activity of AKT may be of therapeutic value in Fas-mediated progressive liver cell injury and liver diseases.

21 March 2016 in Oncotarget
Verified
Journal Article
Open access
FZFengxin Zhu
Fengxin Zhu
WLWei Liu
Wei Liu
TLTang Li
Tang Li
JWJiao Wan
Jiao Wan
JTJianwei Tian
Jianwei Tian
JNJing Nie
Jing Nie
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Fengxin Zhu1, Wei Liu2, Tang Li3, Jiao Wan1, Jianwei Tian1, Zhanmei Zhou1, Hao Li1, Youhua Liu1, Fan Fan Hou1, Jing Nie1 1State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China 2Department of Nephrology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Geriatric Institute, Guangzhou, P.R. China 3The VIP Medical Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, P.R. China Correspondence to: Jing Nie e-mail: niejing@smu.edu.cn Keywords: Numb, G2/M arrest, p53, proximal tubular cells, interstitial fibrosis Received: November 30, 2015 Accepted: March 06, 2016 Published: March 21, 2016